| Literature DB >> 26019478 |
Yi-Ping Zhu1, Yan-Min Chen1, Erik Matro1, Ren-Biao Chen1, Zhi-Nong Jiang1, Yi-Ping Mou1, Hong-Jie Hu1, Chao-Jie Huang1, Guan-Yu Wang1.
Abstract
Primary hepatic angiosarcoma (PHA) is a rare malignancy that carries a poor prognosis. Of 1500 patients who underwent hepatectomy for primary hepatic tumors between 1994 and 2013 at our center, two patients were pathologically diagnosed with PHA. Clinical characteristics, treatment modalities, and outcomes of the two patients were collected and analyzed. Both patients underwent hepatectomy and had a postoperative survival time of 8 and 16 mo, respectively. A search of PubMed yielded eight references reporting 35 cases of PHA published between 2004 and 2013. On the basis of the presented cases and review of the literature, we endorse complete surgical resection as the mainstay definitive treatment of PHA, with adjuvant postoperative chemotherapy potentially improving survival. Palliative chemotherapy is an option in advanced hepatic angiosarcoma.Entities:
Keywords: Diagnosis; Hemangiosarcoma; Liver; Surgery; Therapy
Mesh:
Substances:
Year: 2015 PMID: 26019478 PMCID: PMC4438048 DOI: 10.3748/wjg.v21.i19.6088
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742